SCNX (Scienture Holdings, Inc. Common Stock) Stock Analysis - AI Report

Scienture Holdings, Inc. Common Stock (SCNX) is a publicly traded Healthcare sector company. As of May 21, 2026, SCNX trades at $0.39 with a market cap of $15.99M and a P/E ratio of -0.14. SCNX moved -2.15% today. Year to date, SCNX is -25.14%; over the trailing twelve months it is -57.40%. Its 52-week range spans $0.24 to $9.55. Analyst consensus is buy with an average price target of $1.50. Rallies surfaces SCNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on SCNX?

Rallies AI research for SCNX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

SCNX Key Metrics

Key financial metrics for SCNX
MetricValue
Price$0.39
Market Cap$15.99M
P/E Ratio-0.14
EPS$-2.70
Dividend Yield0.00%
52-Week High$9.55
52-Week Low$0.24
Volume6.76K
Avg Volume0
Revenue (TTM)$431.61K
Net Income$-41.51M
Gross Margin76.80%

Latest SCNX News

SCNX Analyst Consensus

1 analysts cover SCNX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.50.

Common questions about SCNX

What is the AI research view on SCNX?
Rallies AI research for SCNX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for SCNX?
Rallies AI research for SCNX combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is SCNX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SCNX. It does not provide personalized investment advice.
SCNX

SCNX